Page 161 - Pagetit
P. 161

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE




                   Candidate genes involved in substance dependence
                   Candidate gene studies examine alleles that might reasonably be thought to
                   be involved in a disorder. Currently the best candidate allelic variants fulfil at
                   least two criteria: the variant has been shown to alter function, and the variant
                   has a good likelihood of being biologically relevant (Stoltenberg & Burmeister,
                   2000).
                     There are two main types of genes that have been associated with drug
                   dependence; those that are likely to be specific to the particular dependence
                   [e.g. nicotinic receptors and smoking, ethanol metabolism and alcohol
                   dependence (Grant et al., 1999)] and those that may play a common role in
                   either all or a subset of dependencies. Genetic alterations in various
                   combinations of the genes for neurotransmitters and receptors (i.e. serotonin,
                   norepinephrine, GABA, glutamate and opioid) that modify dopamine neuron
                   function may put individuals at risk for dependence (Comings & Blum, 2000;
                   Quattrocki, Baird & Yurgelun-Todd, 2000). Like other behavioural disorders,
                   substance dependence is polygenically (i.e. many genes) inherited and each
                   gene is likely to account for only a small percentage of the variance. In each
                   subsequent section, gene candidates that may affect dependence more
                   generally will follow the candidate genes specific to tobacco, alcohol and
                   opioid dependence.


                   GABAergic systems

                   Inhibition of GABAergic systems in the substantia nigra fine-tunes the amount
                   of dopamine released at the nucleus accumbens, an important site for the
                   effects of all psychoactive substances (see Chapters 3 and 4). GABA  receptor
                                                                           A
                   blockers reduce some ethanol-induced behaviours, such as motor
                   impairment and sedation. The role of this receptor in alcohol dependence is
                   further supported by effective alleviation of alcohol withdrawal symptoms
                   by GABA  agonists (Parsian & Cloninger, 1997). In addition, one of the clusters
                          A
                   of GABA  receptors is located on chromosome 4, at a locus which is thought
                          A
                   to feature prominently in alcohol dependence. Thus the GABAergic system
                   may alter risk for smoking and alcohol dependence (Loh & Ball, 2000).
                     Nicotine can stimulate the firing rate of dopamine neurons in the ventral
                   tegmental area (VTA), but GABAergic neurons may also be an important target
                   for the effects of nicotine on the central nervous system.

                   GABA  receptor α1. No association has been found with any type of substance
                        A
                   dependence (Parsian & Cloninger, 1997).
                   GABA  receptor α3. An association was found for alcohol dependence, but
                        A
                   not with its subtypes (Parsian & Cloninger, 1997).

                   GABA  receptor α6. There is some evidence for the involvement of this receptor
                        A
                   subunit in alcohol dependence, in both animal and human studies. A locus

                                                  140




          Chapter_5                140                             19.1.2004, 11:45
   156   157   158   159   160   161   162   163   164   165   166